secwatch / observer
8-K filed August 11, 2025, 7:59 PM ET ticker FRMM CIK 0001690080
debt confidence high sentiment neutral materiality 0.80

FORUM MARKETS Inc (FRMM): debt financing — 180 Life Sciences closes $150M convertible note financing; appoints Executive Chairman

FORUM MARKETS Inc

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

FORUM MARKETS Inc incurred convertible notes of aggregate principal amount of $156,250,000 with investment funds managed by an institutional investor at 0.00% per annum for the first six months, and 4.00% per annum for the following maturing the third year anniversary of the issuance date of the Convertible Notes.

Instrument
convertible notes
Principal
aggregate principal amount of $156,250,000
Counterparty
investment funds managed by an institutional investor
Rate
0.00% per annum for the first six months, and 4.00% per annum for the following
Maturity
the third year anniversary of the issuance date of the Convertible Notes
Event
incurrence
Exact text from the filing
“ Investor ”), under which the Company agreed to sell and issue to the Investor senior secured convertible notes (the “ Convertible Notes ”) in aggregate principal amount of $156,250,000 (the “ Principal Amount ”) in exchange for cash equal to 96.0% of the Principal Amount (the “ Debt Financing ”). The Company closed the Debt Financing simultaneously with the
View on SEC.gov

101 debt financings filed in the last 30 days. Browse all debt financings →

FORUM MARKETS Inc filing history →

Source: SEC EDGAR
accession 0001213900-25-074030
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.